Ep 2: Carlo Montagner

Carlo Montagner

Co-Founder and CEO, Specialised Therapeutics Australia

Risks and rewards: getting new medications into the hands of patients

In this episode, RCA Chief Executive Richard Vines speaks to Carlo Montagner about:

• His move from psychology to pharma
• Building a strong foundation in the industry
• Founding STA with his wife
• The barriers to, and costs of, supplying drugs in Australia
• How the process can be improved and simplified
• Accessing drugs not listed on the PBS
• The responsibility of clinicians around reimbursement
• The challenges and opportunities of Health Technology Assessment (HTA)
• Why STA is expanding into Asia
• His family’s personal experience with rare cancer
• Why he is passionate about bringing rare cancer drugs to Australia
• His vision for the future

Listen to the episode as a podcast

Read Episode Transcript 

More about Carlo Montagner

Specialised Therapeutics Australia (STA) is a pharmaceutical company that has been instrumental in helping Australians living with rare cancer to access new medications that would otherwise be out of reach. Before co-founding STA, Carlo held senior roles at some of the world’s largest pharmaceutical companies.

More about Richard Vines

Richard is the co-Founder and Chief Executive of Rare Cancers Australia. He is Convener and Co-chair of the National Oncology Alliance, and Deputy Chair of Omico. Richard also serves as an associate investigator on several research projects and is a spokesperson for cancer patient advocacy issues in both Australia and the Asia Pacific region.

Next Episode